ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 159 filers reported holding ZIOPHARM ONCOLOGY INC in Q3 2020. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $74,082 | -91.1% | 114,131 | -76.5% | 0.00% | -89.7% |
| Q3 2022 | $835,000 | -28.1% | 485,434 | -48.2% | 0.03% | -17.1% |
| Q2 2022 | $1,162,000 | +198.7% | 936,900 | +337.8% | 0.04% | +150.0% |
| Q3 2021 | $389,000 | +221.5% | 214,000 | +367.2% | 0.01% | +366.7% |
| Q2 2021 | $121,000 | +181.4% | 45,800 | +166.3% | 0.00% | -50.0% |
| Q3 2020 | $43,000 | – | 17,200 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |